关注
Béziat Vivien
Béziat Vivien
Institut Imagine
在 inserm.fr 的电子邮件经过验证
标题
引用次数
引用次数
年份
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ...
Science 370 (6515), eabd4585, 2020
25822020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ...
Science 370 (6515), eabd4570, 2020
22202020
Cytomegalovirus Infection Drives Adaptive Epigenetic Diversification of NK Cells with Altered Signaling and Effector Function
H Schlums, F Cichocki, B Tesi, J Theorell, V Beziat, TD Holmes, H Han, ...
Immunity 42 (3), 443-456, 2015
7502015
NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs
V Béziat, LL Liu, JA Malmberg, MA Ivarsson, E Sohlberg, AT Björklund, ...
Blood, The Journal of the American Society of Hematology 121 (14), 2678-2688, 2013
5422013
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths
P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ...
Science immunology 6 (62), eabl4340, 2021
4832021
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19
T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ...
Science immunology 6 (62), eabl4348, 2021
3592021
Human NK cells display major phenotypic and functional changes over the life span
M Le Garff‐Tavernier, V Béziat, J Decocq, V Siguret, F Gandjbakhch, ...
Aging cell 9 (4), 527-535, 2010
3502010
CMV drives clonal expansion of NKG2C+ NK cells expressing self‐specific KIRs in chronic hepatitis patients
V Béziat, O Dalgard, T Asselah, P Halfon, P Bedossa, A Boudifa, ...
European journal of immunology 42 (2), 447-457, 2012
3262012
Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity
C Petitdemange, P Becquart, N Wauquier, V Béziat, P Debré, EM Leroy, ...
PLoS pathogens 7 (9), e1002268, 2011
3062011
Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells
N Marquardt, V Béziat, S Nyström, J Hengst, MA Ivarsson, E Kekäläinen, ...
The Journal of Immunology 194 (6), 2467-2471, 2015
2692015
NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs
V Béziat, B Descours, C Parizot, P Debré, V Vieillard
PloS one 5 (8), e11966, 2010
2562010
Critical Role of CD2 Co-stimulation in Adaptive Natural Killer Cell Responses Revealed in NKG2C-Deficient Humans
LL Liu, J Landskron, EH Ask, M Enqvist, E Sohlberg, JA Traherne, ...
Cell Reports 15 (5), 1088-1099, 2016
2362016
Role for early-differentiated natural killer cells in infectious mononucleosis
T Azzi, A Lünemann, A Murer, S Ueda, V Béziat, KJ Malmberg, G Staubli, ...
Blood, The Journal of the American Society of Hematology 124 (16), 2533-2543, 2014
2272014
Class I HLA haplotypes form two schools that educate NK cells in different ways
A Horowitz, Z Djaoud, N Nemat-Gorgani, J Blokhuis, HG Hilton, V Béziat, ...
Science immunology 1 (3), eaag1672-eaag1672, 2016
1982016
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation
V Béziat, D Duffy, SN Quoc, M Le Garff-Tavernier, J Decocq, ...
The Journal of Immunology 186 (12), 6753-6761, 2011
1902011
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity
V Béziat, J Li, JX Lin, CS Ma, P Li, A Bousfiha, I Pellier, S Zoghi, S Baris, ...
Science immunology 3 (24), eaat4956, 2018
1752018
Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency
R Lévy, S Okada, V Béziat, K Moriya, C Liu, LYA Chai, M Migaud, F Hauck, ...
Proceedings of the National Academy of Sciences 113 (51), E8277-E8285, 2016
1622016
Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon‐γ production in patients with active disease
B Hervier, V Beziat, J Haroche, A Mathian, P Lebon, P Ghillani‐Dalbin, ...
Arthritis & Rheumatism 63 (6), 1698-1706, 2011
1622011
Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
P Bastard, E Michailidis, HH Hoffmann, M Chbihi, T Le Voyer, J Rosain, ...
Journal of Experimental Medicine 218 (4), e20202486, 2021
1602021
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ...
Proceedings of the National Academy of Sciences 119 (21), 2022
1442022
系统目前无法执行此操作,请稍后再试。
文章 1–20